Who Paid My Doc
Scott Dulebohn
Neurological Surgery Johnson City, TN Medical Doctor
NPI 1528009198 CMS profile 114416
410 N State Of Franklin Rd, Suite 120, Johnson City, TN 37604
General payments
$7,943
Research payments
$1,320
Ownership & investment interest
$0
Through program year 2025, Scott Dulebohn of Johnson City, TN is reported in the CMS Open Payments database as having received $7,943 across 267 general payments and $1,320 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 68th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $849 | 11 | |
| 2024 | General | $446 | 8 | |
| 2023 | General | $222 | 12 | |
| 2022 | General | $847 | 48 | |
| 2021 | General | $3,623 | 75 | |
| 2020 | General | $831 | 59 | |
| 2020 | Research | $1,320 | 1 | |
| 2019 | General | $1,125 | 54 |
Beside peers
- Scott Dulebohn
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Scott Dulebohn were reported at $849. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Scott Dulebohn | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,125 | $582 | $138–$3,006 | $163 |
| 2020 | $831 | $294 | $76–$2,174 | $114 |
| 2021 | $3,623 | $387 | $105–$2,432 | $132 |
| 2022 | $847 | $542 | $139–$2,989 | $149 |
| 2023 | $222 | $534 | $145–$2,697 | $160 |
| 2024 | $446 | $574 | $155–$3,046 | $164 |
| 2025 | $849 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 47 billing codesPaid by Medicare
$49,114
Medicare patients
182
Services billed
412
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 60% | |
| Diabetes | 55% | |
| Ischemic heart disease | 36% | |
| Heart failure | 29% | |
| Chronic kidney disease | 29% | |
| Osteoporosis | 23% | |
| COPD | 21% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
268 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in Tennessee
Related records
Neurological Surgery in Tennessee
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Tennessee
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.